According to reports from Moneycontrol, Tata Elxsi's shares advanced by 2.02% to ₹3,747.00 in Monday's trading session. The stock is a constituent of the Nifty Midcap 150 index, reflecting positive investor sentiment. As of July 29, 2026, Moneycontrol's sentiment analysis indicates a neutral outlook for the company.
For AI-focused investors, Tata Elxsi stands out as a specialist in applying AI to real-world use cases such as self-driving capabilities, connected vehicles, digital health and MedTech, backed by products like AutonomAI, TETHER and its Digital Health Platform. According to Simply Wall St, the company reports ROE of 21.5% and a 2.04% dividend, yet revenue and earnings growth have recently trailed broader Indian market expectations. The company's expanding AI partnerships in autos and healthcare could influence these pressure points and reshape the overall risk-reward profile.
The company's standalone annual income statement reveals consistent revenue growth over recent years. According to the financial data, sales grew from ₹2,470 crore in March 2022 to ₹3,757 crore in March 2026. However, net profit showed a strong trend from ₹549 crore in March 2022 to ₹784 crore in March 2025, though it declined to ₹628 crore in March 2026. Quarterly sales have steadily risen, reaching ₹1,021 crore in the quarter ending June 2026, with net profit for the quarter standing at ₹170 crore. Margins have eased from 20% to 16.7% in recent periods, raising questions about the company's competitive positioning.
The company's cash flow from operating activities remained strong, reaching ₹663 crore in March 2026, indicating the company's ability to generate cash from core operations. As reported by Moneycontrol, cash flow from investing activities showed negative ₹72 crore in March 2026, while financing activities showed negative ₹534 crore. The company's total assets have grown consistently, reaching ₹3,962 crore in March 2026, while maintaining a debt-to-equity ratio of 0.00, signifying no debt. However, Simply Wall St notes that rising reliance on external borrowings and a share price above some fair value estimates raise valuation and balance sheet questions.
According to the financial data, basic EPS decreased to ₹100.89 in March 2026 from ₹126.03 in March 2025. The net profit margin declined to 16.72% in March 2026 from 21.04% in March 2025. However, the company maintains a strong current ratio of 3.92 and quick ratio of 3.92 in March 2026, indicating healthy liquidity position. Return on networth/equity stood at 20.66% in March 2026, while ROCE remained robust at 29.23%. The company's return on equity of 21.5% demonstrates strong operational efficiency despite recent margin pressures.
